Question 1

Who are the top researchers at Theracos (United States)?

Accepted Answer

Ranked on the quality score, Zelin Sheng and Baihua Xu lead among researchers whose main affiliation is Theracos (United States).

Question 2

What are the most cited papers from Theracos (United States)?

Accepted Answer

The most cited paper from Theracos (United States) is "EGT1442, a potent and selective SGLT2 inhibitor, attenuates blood glucose and HbA1c levels in db/db mice and prolongs the survival of stroke-prone rats" (Wenbin Zhang, Ajith A. Welihinda, Jordan Mechanic et al., 2011), with 76 citations. Next come "Design, Synthesis, and Biological Evaluation of Deuterated C-Aryl Glycoside as a Potent and Long-Acting Renal Sodium-Dependent Glucose Cotransporter 2 Inhibitor for the Treatment of Type 2 Diabetes" (66) and "A 96‐week, multinational, randomized, double‐blind, parallel‐group, clinical trial evaluating the safety and effectiveness of bexagliflozin as a monotherapy for adults with type 2 diabetes" (43).

Question 3

Which research topics does Theracos (United States) publish most on?

Accepted Answer

By volume in 2022-now: Microbial bioremediation and biosurfactants, Carcinogens and Genotoxicity Assessment, Toxic Organic Pollutants Impact and Linguistic, Cultural, and Literary Studies.

Question 4

Which fields of science does Theracos (United States) work in?

Accepted Answer

In all years, 42% of research at Theracos (United States) is in Health Sciences, 30% in Physical Sciences. Its largest fields are Medicine (42%), Social Sciences (15%), Environmental Science (13%).

Question 5

Is Theracos (United States)'s research output growing?

Accepted Answer

Output in 2022-2025 was 96% higher than in 2018-2021.